your relationship with glaxo.eparing to buy out the state that novartis holds in the consumer health business, the joint venture you have with them. you have an option to sell your stake back to glaxo in march. what is your thinking on that as it stands at the moment? joseph: we are very pleased with the way glaxo is managing a business. the business trendline has shown good topline growth and they are showing very good margin improvement on the business. as you know, when we entered that joint venture, we said our business was too small that the global scale we need to get margins up and get growth rates up. i think we are proving that combining that by these businesses, you end up with a bigger and stronger business. while it is true we have the ability to put our shares, 2018, we in spring of have made no decision to do so. that is because the value of this asset for novartis continues to grow. we are going to continue to watch the way that the business performance and we will make a decision as we go. manus: j

glaxo smith kline said they were not supportive of the action and astrazeneca also said they had reservationsere that goes. on some sport now. i know you love sport. you particularly love that manchester united bought lukaku. that manchester united bought lu ka ku. you that manchester united bought lukaku. you prefer tennis. rafael nadal is out. it is the first time that they will have a british man and woman in the topic.|j that they will have a british man and woman in the topic. i was not at wimbledon today, i was there on friday. i was there last week and i saw rafael nadal and i thought he was at the peak of his powers. he came back fantastically and then this titanic 15—13 in the final set. he should have drank more coffee. we need to leave it there because we are out of time. it was good to see you both and thank you. don't forget you can see the front pages of the papers online on the bbc news website. it's all there for you — seven days a week at bbc.co.uk/papers. and if you miss the programme any evening, you can watch it later on bbc iplayer. thank you, katy balls and david davies.

important stuff it's played out dude i mean some of the pows advertize include corporate to him it's like glaxo smith kline pharmaceuticals bank of america and koch industries we all know those three entities are grinding america into another's hell's gate of epic despair hit me with something rash. that's not for what look like what i don't know maybe post a new story about how humans having sex with birds isn't as weird as you think. or maybe one about how amazon has six hundred million dollar contracts with the cia you know what the second one. but you're on jeff jeff bezos is the c.e.o. of amazon and he's also the owner of the washington post so on officially the cia is a funder of the washington post what do you play implying that because of the bezos approved policy that won't let washed. critique advertisers that somehow that means they're not going to be critical of the cia i mean have some more faith in wash. ok first stop doing that and secondly i'm not implying that they won't criticize the guy a i'm saying that i said that i just said it i don't know why are we already know that out

glaxo welcome to bloomberg businessweek. if issuing to grow new skin. they are trying to protect germany's cautions and spaces getting closer and cheaper than you think. like all of that i had on bloomberg businessweek. that ahead on bloomberg businessweek. >> we are here with the editor-in-chief of bloomberg businessweek. artificial skin, using his skin. >> yes, this skin is rich in materials that are very helpful in healing wounds for people who forget about the people who are appointed with persistent wound care. whether you have diabetes or a burn. they really have developed a this market with their skin. this can be used and it is testing better. i didn't know that another product being used is pig intestines. what we want to show is that the future is here. andre adopting products adopting things that we never thought was possible. it really goes into something you probably have never heard of and you should probably know. hundreds of millions of people supper from wounds around the world. this could be a breakthrough. oliver: this harkens back to

glaxo welcome to bloomberg businessweek. if issuing to grow new skin.protect germany's cautions and spaces getting closer and cheaper than you think. like all of that i had on bloomberg businessweek. that ahead on bloomberg businessweek. >> we are here with the editor-in-chief of bloomberg businessweek. artificial